Genomics

Dataset Information

0

Gene expression profiling in TPC1 cell line treated with the RTK inhibitor RPI-1

ABSTRACT: We treated the papillary thyroid carcinoma-derived cell line TPC1 with the RTK inhibitor RPI-1 to obtain a thyroid carcinoma cell model. The RET tyrosine kinase is a target of the inhibitor. Gene expression changes were evaluated comparing cells treated with the inhibitor for 24 hours versus cells treated with DMSO for 24 hours.

ORGANISM(S): Homo sapiens

PROVIDER: GSE49414 | GEO | 2014/06/30

SECONDARY ACCESSION(S): PRJNA213907

REPOSITORIES: GEO

Json Xml

Similar Datasets

Unknown microRNA expression profiling in TPC1 cell line treated with the RTK inhibitor RPI-1
2014-06-30 | GSE49401 | GEO
Transcriptomics Gene expression profiling in TPC1 cell line treated with the RTK inhibitor RPI-1
2014-06-30 | E-GEOD-49414 | biostudies-arrayexpress
Transcriptomics microRNA expression profiling in TPC1 cell line treated with the RTK inhibitor RPI-1
2014-06-30 | E-GEOD-49401 | biostudies-arrayexpress
Transcriptomics Papillary thyroid cancer cell lines treated with Y15
2014-03-06 | E-GEOD-55603 | biostudies-arrayexpress
Genomics Homo sapiens
| PRJNA213907 | ENA
Genomics Homo sapiens
| PRJNA213905 | ENA
Transcriptomics mRNA-seq of human cells lines derived from Papillary thyroid carcinoma (TPC1) transfected with siRNA against BHLHE40 (DEC1) or with scramble control siRNA
2018-09-03 | E-MTAB-6394 | biostudies-arrayexpress
Transcriptomics Magnaporthe oryzae, comparison between WT and Tpc1 mutant
2017-04-03 | E-MTAB-4127 | biostudies-arrayexpress
Genomics Reconstructing the RUNX2 transcriptional hierarchy in thyroid cancer using a multi-layered network- based approach (ChIP-seq RUNX2)
2023-10-20 | E-MTAB-11051 | biostudies-arrayexpress
Genomics Gene expression changes caused by treatment of TPC1 cells with RET inhibitor BLU6864 from 6 to 24 hours [BLU6864_24H vs BLU6864_6H]
| PRJNA818801 | ENA